THERAPEUTIC OR PREVENTIVE AGENT FOR TUMOUR LYSIS SYNDROME

摘要

FIELD: medicine.;SUBSTANCE: 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid is used as a therapeutic agent for tumour lysis syndrome treatment or prevention, which is injected at the rate of 0.5 up to 1000 mg/day, from 1 to 7 days/week.;EFFECT: use of the invention can improve kidney function after antitumor therapy.;12 cl, 4 tbl, 4 dwg, 3 ex